Similar articles for PMID: 32002574

Year	Number of Results
1996	1
1999	1
2004	2
2005	3
2006	4
2007	6
2008	7
2009	4
2010	8
2011	10
2012	9
2013	11
2014	16
2015	11
2016	10
2017	8
2018	13
2019	9
2020	6
2021	14
2022	9
2023	6
2024	0

1

Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.

Szymaszkiewicz A, Włodarczyk J, Wasilewski A, Di Marzo V, Storr M, Fichna J, Zielińska M. Szymaszkiewicz A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2020 Aug;393(8):1357-1364. doi: 10.1007/s00210-020-01829-x. Epub 2020 Jan 30. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32002574 Free PMC article.

2

Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Zielińska M, Jarmuż A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J. Zielińska M, et al. Pharmacol Rep. 2017 Apr;69(2):350-357. doi: 10.1016/j.pharep.2016.12.001. Epub 2016 Dec 5. Pharmacol Rep. 2017. PMID: 28187396 Free PMC article.

3

Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.

Sobczak M, Cami-Kobeci G, Sałaga M, Husbands SM, Fichna J. Sobczak M, et al. Eur J Pharmacol. 2014 Aug 5;736:63-9. doi: 10.1016/j.ejphar.2014.04.038. Epub 2014 May 6. Eur J Pharmacol. 2014. PMID: 24815321 Free PMC article.

4

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.

Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-Panas E, Wlaź P, Krajewska WM, Fichna J. Zielińska M, et al. J Pharm Pharmacol. 2015 Feb;67(2):244-54. doi: 10.1111/jphp.12335. Epub 2014 Dec 17. J Pharm Pharmacol. 2015. PMID: 25515402

5

N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.

De Petrocellis L, Guida F, Moriello AS, De Chiaro M, Piscitelli F, de Novellis V, Maione S, Di Marzo V. De Petrocellis L, et al. Pharmacol Res. 2011 Apr;63(4):294-9. doi: 10.1016/j.phrs.2010.12.019. Epub 2011 Jan 5. Pharmacol Res. 2011. PMID: 21215315

6

Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission.

Fichna J, Poole DP, Veldhuis N, MacEachern SJ, Saur D, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Małecka-Panas E, Krajewska WM, Liedtke W, Steinhoff MS, Timmermans JP, Bunnett NW, Sharkey KA, Storr MA. Fichna J, et al. J Mol Med (Berl). 2015 Dec;93(12):1297-309. doi: 10.1007/s00109-015-1336-5. Epub 2015 Sep 2. J Mol Med (Berl). 2015. PMID: 26330151

7

Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.

Wouters MM, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar YA, Valdez-Morales EE, Nasser Y, Van Veldhoven PP, Vanbrabant W, Van der Merwe S, Mols R, Ghesquière B, Cirillo C, Kortekaas I, Carmeliet P, Peetermans WE, Vermeire S, Rutgeerts P, Augustijns P, Hellings PW, Belmans A, Vanner S, Bulmer DC, Talavera K, Vanden Berghe P, Liston A, Boeckxstaens GE. Wouters MM, et al. Gastroenterology. 2016 Apr;150(4):875-87.e9. doi: 10.1053/j.gastro.2015.12.034. Epub 2016 Jan 2. Gastroenterology. 2016. PMID: 26752109 Clinical Trial.

8

Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.

Zielińska M, Jarmuż A, Sałaga M, Lipkowski AW, Fichna J. Zielińska M, et al. Pharmacol Rep. 2016 Feb;68(1):32-6. doi: 10.1016/j.pharep.2015.06.001. Epub 2015 Jun 12. Pharmacol Rep. 2016. PMID: 26721348

9

Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Capasso R, Orlando P, Pagano E, Aveta T, Buono L, Borrelli F, Di Marzo V, Izzo AA. Capasso R, et al. Br J Pharmacol. 2014 Sep;171(17):4026-37. doi: 10.1111/bph.12759. Br J Pharmacol. 2014. PMID: 24818658 Free PMC article.

10

Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.

Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ. Shi HL, et al. World J Gastroenterol. 2015 Apr 28;21(16):4852-63. doi: 10.3748/wjg.v21.i16.4852. World J Gastroenterol. 2015. PMID: 25944998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year